Chen, G <br/><br/>
Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cells.  [electronic resource] 

 -  Anticancer research   
 - 3499-505 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--antagonists & inhibitors<br/>Anthraquinones--metabolism<br/>Antineoplastic Agents--metabolism<br/>Aporphines--metabolism<br/>Benzylisoquinolines<br/>Breast Neoplasms--metabolism<br/>Doxorubicin--metabolism<br/>Drug Interactions<br/>Etoposide--metabolism<br/>Humans<br/>Isoquinolines--metabolism<br/>Paclitaxel--metabolism<br/>Pyrazoles--metabolism<br/>Pyrazolones<br/>Tumor Cells, Cultured--drug effects